Fusion Family Wealth’s AbbVie ABBV Stock Holding History

Fusion Family Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-103	Closed	-$11K	–	38
2021 Q1	$11K	Hold	103	–	–	﹤0.01%	82
2020 Q4	$11K	Sell	103 -210	-67%	-$20.2K	﹤0.01%	75
2020 Q3	$27K	Buy	313 +87	+38%	+$8.19K	0.01%	65
2020 Q2	$22K	Buy	226 +123	+119%	+$10.8K	0.01%	69
2020 Q1	$8K	Hold	103	–	–	﹤0.01%	91
2019 Q4	$9K	Hold	103	–	–	﹤0.01%	99
2019 Q3	$8K	Sell	103 -107	-51%	-$7.34K	﹤0.01%	106
2019 Q2	$15K	Buy	210 +107	+104%	+$8.41K	﹤0.01%	106
2019 Q1	$8K	Sell	103 -107	-51%	-$8.75K	﹤0.01%	115
2018 Q4	$19K	Hold	210	–	–	0.01%	158
2018 Q3	$20K	Sell	210 -39	-16%	-$3.7K	0.01%	167
2018 Q2	$23K	Buy	249 +103	+71%	+$10.1K	0.01%	177
2018 Q1	$14K	Hold	146	–	–	﹤0.01%	186
2017 Q4	$14K	Buy	+146	New	+$13.8K	﹤0.01%	197
2017 Q3	–	Sell	-146	Closed	-$11K	–	228
2017 Q2	$11K	Sell	146 -41	-22%	-$2.76K	﹤0.01%	197
2017 Q1	$12K	Sell	187 -594	-76%	-$37.3K	﹤0.01%	196
2016 Q4	$48K	Buy	+781	New	+$47.7K	0.03%	125

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Fusion Family Wealth's ABBV Position: Q2 2021 in Review

Fusion Family Wealth sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 103 shares — an estimated $11K sold.

Fusion Family Wealth first reported a position in ABBV in Q4 2016 and held it in 17 quarters. The position peaked at $48K in Q4 2016. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Fusion Family Wealth reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
Fusion Family Wealth sold 103 AbbVie shares in Q2 2021, an estimated $11K.
Fusion Family Wealth first reported a position in AbbVie in Q4 2016 and held it in 17 quarters.
Fusion Family Wealth's AbbVie position peaked at $48K in Q4 2016.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Fusion Family Wealth's 13F filing for Q2 2021, filed 30 Jul 2021.